List view / Grid view
Biomarkers are a naturally occurring molecule, gene, or characteristic by which a particular disease can be identified.
29 January 2016 | By SMi Group
SMi group reports: Doug Johnson, Research Fellow at Pfizer will be giving a keynote address on Day 1 at the SMi’s 15th annual Advances and Progress in Drug Design conference...
29 January 2016 | By Victoria White
The lab headed by Thomas Helleday at Karolinska Institutet and Biovica are to collaborate to improve evaluation of new, promising cancer therapies...
22 January 2016 | By Victoria White
The research from Georgia State University scientists provides strong translational potential with respect to biomarkers that play critical roles in the development of endometrial/lung tumours...
11 December 2015 | By Victoria White
The companies have joined WCPR to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome...
3 December 2015 | By Drug Target Review
Included in this issue: Biomarkers, Mass Spectrometry, Target Validation, Drug Development, Personalised Medicines, Next-Generation Sequencing, Protein Expression, Companion Diagnostics, and much more...
Knowledge about cancer biomarkers has increased tremendously and provides clinicians and researchers with valued opportunities to understand the molecular mechanism of cancer, thus applying it to effective, early-stage diagnosis and treatment. Cancer biomarkers include a vast range of biochemical molecules such as nucleic acids, proteins, sugars, lipids, small metabolites, cytogenetic…
Simple Plex assays run on Ella™ enabled simultaneous quantitation of four analytes from eight samples in a disposable cartridge in under an hour...
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
21 September 2015 | By SomaLogic
The SOMAscan™ assay is a highly multiplexed, sensitive, quantitative and reproducible proteomic tool for discovering biomarkers for drug discovery...
17 September 2015 | By Victoria White
The researchers also determined that the level of biomarkers associated with ovarian cancer does not simply increase or decrease over the course of the disease...
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
7 July 2015 | By Victoria White
Researchers have created a first-of-its-kind animal model to pinpoint two biomarkers that are elevated in the most severe form atherosclerosis...
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
18 June 2015 | By Victoria White
New research has revealed two genes that could help physicians make more informed treatment decisions for patients with colorectal cancer...
15 June 2015 | By Victoria White
Scientists from Lund University have discovered that expression of ALK1 is significantly associated with the incidence of breast cancer metastasis...
